Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 37 | Larson Keith DGeneral Counsel and Secretary |  VGVenture Global, Inc.Open-market sale · 10b5-1 plan | SELL | $28.69M 1.89M sh | Sep 9, 2026 |
| 36 | Collier CharlesPresident, Roku Media | ROKUROKU, INC Open-market sale · 10b5-1 plan | SELL | $1.39M 8,843 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 36 | Collier CharlesPresident, Roku Media | ROKUROKU, INC Open-market sale · 10b5-1 plan | SELL | $1.39M 8,843 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 36 | Carlson MeganCAO and SVP, Finance |  BFLYButterfly Network, Inc.Open-market sale | SELL | $101K 13.8K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 35 | Budur KumarCHIEF MEDICAL OFFICER |  HRMYHarmony Biosciences Holdings, Inc.Open-market sale | SELL | $989K 23.0K sh | Sep 9, 2026 traded Sep 8, 2026 |
| 35 | Lin Elizabeth YeuChief Medical Officer |  TARSTarsus Pharmaceuticals, Inc.Open-market sale · 10b5-1 plan | SELL | $485K 5,386 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 35 | Dotan SaarEVP Countries & BD |  ZIMZIM Integrated Shipping Services Ltd.Open-market sale | SELL | $88K 2,890 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 34 | Sluis FrankCFO |  ONONOn Holding AGOpen-market sale | SELL | $19K 687 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 34 | Larson Keith DGeneral Counsel and Secretary | VGVenture Global, Inc. Open-market sale · 10b5-1 plan | SELL | $6.98M 464.2K sh | Sep 9, 2026 traded Sep 8, 2026 |
| 32 | Chin Peter ScottChief Medical Officer |  DNLIDenali Therapeutics Inc.Open-market sale | SELL | $37K 1,654 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 32 | Lindgardt ZhenyaDirector, Chief Executive Officer |  SERASERA PROGNOSTICS, INC.Open-market sale | SELL | $40K 20.1K sh | Sep 9, 2026 traded Sep 8, 2026 |
| 32 | Lin Elizabeth YeuChief Medical Officer | TARSTarsus Pharmaceuticals, Inc. Open-market sale · 10b5-1 plan | SELL | $143K 1,590 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 32 | Dotan SaarEVP Countries & BD | ZIMZIM Integrated Shipping Services Ltd. Open-market sale | SELL | $24K 800 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 32 | Clerc AlexandreSVP, Customers |  ULCCFrontier Group Holdings, Inc.Open-market sale | SELL | $20K 3,480 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 31 | Lin Elizabeth YeuChief Medical Officer | TARSTarsus Pharmaceuticals, Inc. Open-market sale · 10b5-1 plan | SELL | $458K 5,387 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 30 | Phillips DominicSEE REMARKS | IOTSamsara Inc. Open-market sale · 10b5-1 plan | SELL | $793K 17.9K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 30 | Phillips DominicSEE REMARKS | IOTSamsara Inc. Open-market sale · 10b5-1 plan | SELL | $518K 11.7K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 56 | Cheng LawrenceDirector |  GMEGameStop Corp.Open-market purchase | BUY | $1.03M 55.0K sh | Sep 8, 2026 traded Sep 8, 2026 |
| 56 | Marks Peter AshleyDirector |  ATHEALTERITY THERAPEUTICS LTDOpen-market purchase | BUY | $24K 47.6K sh | Sep 8, 2026 traded Aug 31, 2026 |
| 56 | Stamler David AllenDirector, Chief Executive Officer | ATHEALTERITY THERAPEUTICS LTD Open-market purchase | BUY | $24K 47.6K sh | Sep 8, 2026 traded Aug 31, 2026 |
| 52 | Marks Peter AshleyDirector | ATHEALTERITY THERAPEUTICS LTD Open-market purchase | BUY | $24K 47.6K sh | Sep 8, 2026 traded Aug 31, 2026 |
| 51 | Roeder Clinton WilliamChief Financial Officer |  TISITEAM INCOpen-market purchase | BUY | $221K 8,000 sh | Sep 8, 2026 traded Sep 3, 2026 |
| 51 | Speth RalfDirector |  SHMDSCHMID Group N.V.Open-market purchase | BUY | $114K 35.0K sh | Sep 8, 2026 traded Aug 31, 2026 |
| 48 | Meyer-Gloeckner Birger JohannesDirector | ZIMZIM Integrated Shipping Services Ltd. Open-market sale | SELL | $44K 1,531 sh | Sep 8, 2026 traded Sep 4, 2026 |
| 46 | ADAR1 Capital Management, LLC10% Owner |  TENXTENAX THERAPEUTICS, INC.Open-market purchase | BUY | $1.60M 900.0K sh | Sep 8, 2026 traded Sep 3, 2026 |
| 46 | Wambeke David J.Chief Business Officer |  NMTCNEUROONE MEDICAL TECHNOLOGIES CorpOpen-market purchase | BUY | $67K 33.3K sh | Sep 8, 2026 traded Aug 27, 2026 |
| 43 | Speth RalfDirector | SHMDSCHMID Group N.V. Open-market purchase | BUY | $101K 33.0K sh | Sep 8, 2026 traded Sep 2, 2026 |
| 42 | Macdonald AndrewSee Remarks | UBERUber Technologies, Inc Open-market purchase | BUY | $4.11M 54.3K sh | Sep 8, 2026 traded Sep 4, 2026 |
| 41 | Bradford Tonya WilliamsDirector |  LOBLive Oak Bancshares, Inc.Open-market sale | SELL | $64K 1,600 sh | Sep 8, 2026 traded Sep 3, 2026 |
| 38 | Macdonald AndrewSee Remarks | UBERUber Technologies, Inc Open-market purchase | BUY | $1.20M 15.7K sh | Sep 8, 2026 traded Sep 4, 2026 |
| 36 | Courtney Mark RVice President of Supply Chain |  KTCCKEY TRONIC CORPOpen-market sale | SELL | $1,324 566 sh | Sep 8, 2026 traded Sep 4, 2026 |
| 36 | Agress Adam LEVP Business Development | KTCCKEY TRONIC CORP Open-market sale | SELL | $2,602 1,112 sh | Sep 8, 2026 traded Sep 4, 2026 |
| 36 | Musa FernandoDirector |  PCTPureCycle Technologies, Inc.Open-market purchase | BUY | $99K 15.5K sh | Sep 8, 2026 traded Sep 4, 2026 |
| 36 | Voorhees Anthony GeneEVP-Admin, CFO, Treasurer | KTCCKEY TRONIC CORP Open-market sale | SELL | $3,283 1,403 sh | Sep 8, 2026 traded Sep 4, 2026 |
| 34 | Lantheus Alpha Therapy, LLC10% Owner |  CATXPerspective Therapeutics, Inc.Open-market sale | SELL | $251K 80.8K sh | Sep 8, 2026 traded Sep 3, 2026 |
| 33 | Grayson Blake JeffreyChief Financial Officer |  DOCUDOCUSIGN, INC.Open-market sale · 10b5-1 plan | SELL | $2.10M 30.0K sh | Sep 8, 2026 traded Sep 4, 2026 |
| 32 | Sever MichalCMO |  NYAXNayax Ltd.Open-market sale | SELL | $1,779 34 sh | Sep 8, 2026 traded Sep 4, 2026 |
| 32 | Berho Carranza DiegoChief Portfolio Officer |  VTMXVesta Real Estate Corporation, S.A.B. de C.V.Open-market sale | SELL | $22K 6,219 sh | Sep 8, 2026 traded Sep 4, 2026 |
| 32 | McLaughlin Matthew F.Director, Chief Executive Officer |  SCORCOMSCORE, INC.Open-market purchase | BUY | $84K 16.6K sh | Sep 8, 2026 traded Sep 4, 2026 |
| 31 | Bernstein HaroldPresident, R&D & CMO | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $255K 9,705 sh | Sep 8, 2026 traded Sep 4, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
BCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K